DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Drug
Description in Trials
/
DrugBank
/
KEGG DRUG
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
descriptions per page:
Showing 1 to 9 of 9 descriptions
Filter by
Reset
|
No.
Drug (Description in trials)
DrugBank
KEGG DRUG
KEGG GENES
KEGG PATHWAY
Disease ID
1
ACZ885 150 mg (
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
1. ACZ885 150 mg (
Canakinumab
)
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
1. ACZ885 150 mg (
Canakinumab
)
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[1]
107
107
💬
1. ACZ885 150 mg (
Canakinumab
)
×
Disease ID
Name
107
Juvenile idiopathic arthritis
2
Canakinumab
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
2.
Canakinumab
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
2.
Canakinumab
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[10]
46
46
,
56
,
84
,
106
,
107
,
108
,
113
,
266
,
267
,
269
💬
2.
Canakinumab
×
Disease ID
Name
46
Malignant rheumatoid arthritis
56
Behcet disease
84
Sarcoidosis
106
Cryopyrin-associated periodic syndrome
107
Juvenile idiopathic arthritis
108
TNF receptor-associated periodic syndrome
113
Muscular dystrophy
266
Familial mediterranean fever
267
Hyper-IgD syndrome
269
Pyogenic arthritis
3
Canakinumab
(ACZ885)
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
3.
Canakinumab
(ACZ885)
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
3.
Canakinumab
(ACZ885)
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[1]
106
106
💬
3.
Canakinumab
(ACZ885)
×
Disease ID
Name
106
Cryopyrin-associated periodic syndrome
4
Canakinumab
(company code: ACZ885D)
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
4.
Canakinumab
(company code: ACZ885D)
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
4.
Canakinumab
(company code: ACZ885D)
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[1]
106
106
💬
4.
Canakinumab
(company code: ACZ885D)
×
Disease ID
Name
106
Cryopyrin-associated periodic syndrome
5
Canakinumab
(investigational)
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
5.
Canakinumab
(investigational)
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
5.
Canakinumab
(investigational)
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[1]
46
46
💬
5.
Canakinumab
(investigational)
×
Disease ID
Name
46
Malignant rheumatoid arthritis
6
Canakinumab
(proposed)
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
6.
Canakinumab
(proposed)
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
6.
Canakinumab
(proposed)
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[1]
46
46
💬
6.
Canakinumab
(proposed)
×
Disease ID
Name
46
Malignant rheumatoid arthritis
7
Canakinumab
(WHO approval pending)
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
7.
Canakinumab
(WHO approval pending)
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
7.
Canakinumab
(WHO approval pending)
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[1]
106
106
💬
7.
Canakinumab
(WHO approval pending)
×
Disease ID
Name
106
Cryopyrin-associated periodic syndrome
8
Canakinumab
Injection
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
8.
Canakinumab
Injection
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
8.
Canakinumab
Injection
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[1]
46
46
💬
8.
Canakinumab
Injection
×
Disease ID
Name
46
Malignant rheumatoid arthritis
9
Canakinumab
Injection [Ilaris]
[1]
Canakinumab
Canakinumab
(
Canakinumab
)
[1]
Canakinumab
Canakinumab
(
Canakinumab
,
Canakinumab
)
💬
9.
Canakinumab
Injection [Ilaris]
×
Name
Other Names
Canakinumab
Canakinumab (USAN/INN)
Canakinumab (genetical recombination) (JAN)
Ilaris (TN)
[1]
IL1B
IL1B
💬
9.
Canakinumab
Injection [Ilaris]
×
Name
Full Name
IL1B
interleukin 1 beta
[44]
AGE-RAGE signaling pathway in diabetic complications
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver disease
,
Alzheimer disease
,
Amoebiasis
,
Antifolate resistance
,
C-type lectin receptor signaling pathway
,
Chagas disease
,
Coronavirus disease - COVID-19
,
Cytokine-cytokine receptor interaction
,
Cytosolic DNA-sensing pathway
,
Fluid shear stress and atherosclerosis
,
Graft-versus-host disease
,
Hematopoietic cell lineage
,
Herpes simplex virus 1 infection
,
Human cytomegalovirus infection
,
IL-17 signaling pathway
,
Inflammatory bowel disease
,
Inflammatory mediator regulation of TRP channels
,
Influenza A
,
Legionellosis
,
Leishmaniasis
,
Lipid and atherosclerosis
,
MAPK signaling pathway
,
Malaria
,
Measles
,
NF-kappa B signaling pathway
,
NOD-like receptor signaling pathway
,
Necroptosis
,
Non-alcoholic fatty liver disease
,
Osteoclast differentiation
,
Pathogenic Escherichia coli infection
,
Pathways of neurodegeneration - multiple diseases
,
Pertussis
,
Prion disease
,
Rheumatoid arthritis
,
Salmonella infection
,
Shigellosis
,
TNF signaling pathway
,
Th17 cell differentiation
,
Toll-like receptor signaling pathway
,
Tuberculosis
,
Type I diabetes mellitus
,
Yersinia infection
💬
[44]
AGE-RAGE signaling pathway in diabetic complications
,
African trypanosomiasis
,
Alcoholic liver
...
[1]
113
113
💬
9.
Canakinumab
Injection [Ilaris]
×
Disease ID
Name
113
Muscular dystrophy